Literature DB >> 8243319

The murine Niemann-Pick type C lesion affects testosterone production.

C F Roff1, J F Strauss, E Goldin, H Jaffe, M C Patterson, G C Agritellis, A M Hibbs, M Garfield, R O Brady, P G Pentchev.   

Abstract

We have determined the effects of the Niemann-Pick type C (NPC) lesion, which impairs transport of cholesterol from lysosomes, on the androgenic status of male NPC mice. The mice have low serum testosterone levels resulting from decreased testosterone secretion. Testosterone secretion is reduced in NPC mouse testes incubated with 8-bromo-cAMP, 20 alpha-hydroxycholesterol, and pregnenolone compared to testosterone release by normal mouse testes under identical conditions. Ultrastructural examination of testes revealed a paucity of lipid droplets, extensive accumulation of inclusion bodies, and distorted endoplasmic reticulum in Leydig cells of adult NPC mice. The hypoandrogenemia caused systemic deficiencies in NPC mice. Seminal vesicles, a testosterone-responsive tissue, were underdeveloped in NPC male mice. The testosterone-responsive kidney beta-glucuronidase activity was also underexpressed. Seminal vesicle mass and beta-glucuronidase activity were increased by testosterone treatment of NPC mice. Many hepatic proteins, identified by microsequencing, were also deficient in NPC male mice. Levels of alpha 2-mu-globulin, glutathione S-transferase-pi, carbonic anhydrase-III, and selenium-binding protein increased in normal male mice during puberty, but did not increase in the NPC male mice. Based on the increases in protein expression during puberty, differential expression in males and females, and the reported involvement of androgens in regulating expression of some of these proteins, deficient expression of most of these proteins in male NPC mice appears to result from low testosterone levels. We conclude that a defect in testicular testosterone production in NPC male mice causes a pleiotropic deficiency in androgen-sensitive expression of proteins in various organs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243319     DOI: 10.1210/endo.133.6.8243319

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Cholesterol in Niemann-Pick Type C disease.

Authors:  Xiaoning Bi; Guanghong Liao
Journal:  Subcell Biochem       Date:  2010

Review 2.  The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.

Authors:  Amel Lamri; Marie Pigeyre; William S Garver; David Meyre
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

3.  MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein.

Authors:  Mark Charman; Barry E Kennedy; Nolan Osborne; Barbara Karten
Journal:  J Lipid Res       Date:  2009-10-29       Impact factor: 5.922

4.  Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C.

Authors:  M Walterfang; M Fietz; L Abel; E Bowman; R Mocellin; D Velakoulis
Journal:  J Inherit Metab Dis       Date:  2009-07-17       Impact factor: 4.982

5.  Expression of Npc1 in glial cells corrects sterility in Npc1(-/-) mice.

Authors:  C Donohue; S Marion; R P Erickson
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

6.  Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.

Authors:  Ya Hui Hung; Mark Walterfang; Leonid Churilov; Lisa Bray; Laura H Jacobson; Kevin J Barnham; Nigel C Jones; Terence J O'Brien; Dennis Velakoulis; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 7.  Neurosteroid regulation of central nervous system development.

Authors:  Synthia H Mellon
Journal:  Pharmacol Ther       Date:  2007-06-16       Impact factor: 12.310

Review 8.  Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.

Authors:  Synthia H Mellon; Wenhui Gong; Marcus D Schonemann
Journal:  Brain Res Rev       Date:  2007-06-12

Review 9.  Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2018-09-13       Impact factor: 3.240

Review 10.  Current Challenges in Understanding the Cellular and Molecular Mechanisms in Niemann-Pick Disease Type C1.

Authors:  Anja U Bräuer; Angela Kuhla; Carsten Holzmann; Andreas Wree; Martin Witt
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.